Health Economics & Outcomes Research: Role of Medical Affairs in Health Outcomes Activities

STUDY OVERVIEW

Health Economics & Outcomes Research groups are involved in many activities that touch on the medical affairs function, such as issues around quality of life and outcomes research. With this overlap come questions about the role of medical affairs in collecting and using health outcomes data.

Best Practices®, LLC conducted this study to inform medical affairs and health outcomes leaders at biopharma companies on benchmarks around the role of medical affairs in collecting and utilizing health outcomes data. In particular, the study presents benchmarks and insights around medical affairs involvement in health outcomes activities, how health outcomes data informs medical affairs' decisions and types of health outcomes data utilized by patients, payers and providers.

This study will inform medical affairs and health outcomes leaders on these questions and others regarding the role of medical affairs in collecting and utilizing health outcomes data.

Study contains three segments: All Companies, Company Size, and Health Outcomes group maturity (age)


KEY TOPICS

• MA’s Role in HO Activities
• MA’s Role in Collecting HO Data
• Utilization of HO Data
• Impact of HO Data on Decisions
  

• Level of medical affairs involvement in listed health outcomes activities (10)
• Role of medical affairs in collecting listed health outcomes data (8)
• Top three types of health outcomes data used with patients, payers and providers
• Effectiveness of health outcomes data in informing listed medical affairs decisions (8)
  

• Medical Affair’s Role in Collecting health outcomes Data: Medical Affairs groups lead data collection for a majority of health outcomes research. MA takes more leading responsibilities in data collection in younger HO groups. In contrast, company size doesn’t have a significant affect on MA’s role in collecting HO data.

Twenty-three medical affairs leaders at 23 top life-science companies participated in this study. In addition, five deep-dive executive interviews were conducted with selected participants.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.